Cargando…

Biomarkers in the diagnosis of lysosomal storage disorders: proteins, lipids, and inhibodies

A biomarker is an analyte indicating the presence of a biological process linked to the clinical manifestations and outcome of a particular disease. In the case of lysosomal storage disorders (LSDs), primary and secondary accumulating metabolites or proteins specifically secreted by storage cells ar...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aerts, Johannes M. F. G., Kallemeijn, Wouter W., Wegdam, Wouter, Joao Ferraz, Maria, van Breemen, Marielle J., Dekker, Nick, Kramer, Gertjan, Poorthuis, Ben J., Groener, Johanna E. M., Cox-Brinkman, Josanne, Rombach, Saskia M., Hollak, Carla E. M., Linthorst, Gabor E., Witte, Martin D., Gold, Henrik, van der Marel, Gijs A., Overkleeft, Herman S., Boot, Rolf G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Netherlands 2011
Materias:	SSIEM Symposium 2010
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3109260/ https://www.ncbi.nlm.nih.gov/pubmed/21445610 http://dx.doi.org/10.1007/s10545-011-9308-6

Ejemplares similares

Consequences of a global enzyme shortage of agalsidase beta in adult Dutch Fabry patients
por: Smid, Bouwien E, et al.
Publicado: (2011)

Stem cell therapy for white matter disorders: don’t forget the microenvironment!
por: Dooves, Stephanie, et al.
Publicado: (2016)

Gene therapy for monogenic liver diseases: clinical successes, current challenges and future prospects
por: Baruteau, Julien, et al.
Publicado: (2017)

Clinical presentation and outcome of riboflavin transporter deficiency: mini review after five years of experience
por: Jaeger, Bregje, et al.
Publicado: (2016)

Mitochondrial transcript maturation and its disorders
por: Van Haute, Lindsey, et al.
Publicado: (2015)

The important role of biochemical and functional studies in the diagnostics of peroxisomal disorders
por: Ferdinandusse, Sacha, et al.
Publicado: (2016)

Opportunities and challenges for antisense oligonucleotide therapies
por: Kuijper, Elsa C., et al.
Publicado: (2020)

Introduction to the Komrower Memorial Lecture 2010
por: Jakobs, Cornelis
Publicado: (2011)

SSIEM reflections 2004–2010: the growing stature of our society
por: Jakobs, Cornelis
Publicado: (2010)

Redox signalling and mitochondrial stress responses; lessons from inborn errors of metabolism
por: Olsen, Rikke K. J., et al.
Publicado: (2015)

Spectrum of combined respiratory chain defects
por: Mayr, Johannes A., et al.
Publicado: (2015)

Sirtuin activation as a therapeutic approach against inborn errors of metabolism
por: Bleeker, Jeannette C., et al.
Publicado: (2016)

From structural biology to designing therapy for inborn errors of metabolism
por: Yue, Wyatt W.
Publicado: (2016)

MtDNA-maintenance defects: syndromes and genes
por: Viscomi, Carlo, et al.
Publicado: (2017)

Amino acid synthesis deficiencies
por: de Koning, T. J.
Publicado: (2017)

Gene therapy for lysosomal storage disorders: recent advances for metachromatic leukodystrophy and mucopolysaccaridosis I
por: Penati, Rachele, et al.
Publicado: (2017)

A primer to gene therapy: Progress, prospects, and problems
por: Zittersteijn, Hidde A., et al.
Publicado: (2020)

Moving towards clinical trials for mitochondrial diseases
por: Pitceathly, Robert D.S., et al.
Publicado: (2020)

Long-Term Effect of Antibodies against Infused Alpha-Galactosidase A in Fabry Disease on Plasma and Urinary (lyso)Gb3 Reduction and Treatment Outcome
por: Rombach, Saskia M., et al.
Publicado: (2012)

Improving test properties for neonatal cystic fibrosis screening in the Netherlands before the nationwide start by May 1st 2011
por: Cornel, Martina C., et al.
Publicado: (2012)

Pathophysiology of fatty acid oxidation disorders and resultant phenotypic variability
por: Olpin, Simon E
Publicado: (2013)

Elevation of glycoprotein nonmetastatic melanoma protein B in type 1 Gaucher disease patients and mouse models
por: Kramer, Gertjan, et al.
Publicado: (2016)

Cost-effectiveness of enzyme replacement therapy for Fabry disease
por: Rombach, Saskia M, et al.
Publicado: (2013)

Poikilothermia in a 38-year-old Fabry patient
por: Biegstraaten, Marieke, et al.
Publicado: (2010)

Detection of Active Mammalian GH31 α-Glucosidases in Health and Disease Using In-Class, Broad-Spectrum Activity-Based Probes
por: Jiang, Jianbing, et al.
Publicado: (2016)

Correction to “Detection of Active Mammalian GH31 α-Glucosidases in Health and Disease Using In-Class, Broad-Spectrum Activity-Based Probes”
por: Jiang, Jianbing, et al.
Publicado: (2017)

Annual General Meeting 2010
por: CERN. Geneva
Publicado: (2010)

Treatment of Fabry Disease: Outcome of a Comparative Trial with Agalsidase Alfa or Beta at a Dose of 0.2 mg/kg
por: Vedder, Anouk C., et al.
Publicado: (2007)

Investigations on therapeutic glucocerebrosidases through paired detection with fluorescent activity-based probes
por: Kallemeijn, Wouter W., et al.
Publicado: (2017)

Long term enzyme replacement therapy for Fabry disease: effectiveness on kidney, heart and brain
por: Rombach, Saskia M, et al.
Publicado: (2013)

Prevalence of symptoms in female Fabry disease patients: a case-control survey
por: Bouwman, Machtelt G., et al.
Publicado: (2012)

Stabilization of Glucocerebrosidase by Active Site Occupancy
por: Ben Bdira, Fredj, et al.
Publicado: (2017)

Spiro‐epoxyglycosides as Activity‐Based Probes for Glycoside Hydrolase Family 99 Endomannosidase/Endomannanase
por: Schröder, Sybrin P., et al.
Publicado: (2018)

Action myoclonus-renal failure syndrome: diagnostic applications of activity-based probes and lipid analysis
por: Gaspar, Paulo, et al.
Publicado: (2014)

Pain management strategies for neuropathic pain in Fabry disease - a systematic review
por: Schuller, Y., et al.
Publicado: (2016)

Erratum to: Pain management strategies for neuropathic pain in Fabry disease - a systematic review
por: Schuller, Y., et al.
Publicado: (2016)

Visualization of Active Glucocerebrosidase in Rodent Brain with High Spatial Resolution following In Situ Labeling with Fluorescent Activity Based Probes
por: Herrera Moro Chao, Daniela, et al.
Publicado: (2015)

In vitro and in vivo comparative and competitive activity-based protein profiling of GH29 α-l-fucosidases
por: Jiang, Jianbing, et al.
Publicado: (2015)

Label-Free LC-MS(e) in Tissue and Serum Reveals Protein Networks Underlying Differences between Benign and Malignant Serous Ovarian Tumors
por: Wegdam, Wouter, et al.
Publicado: (2014)

Human Alpha Galactosidases Transiently Produced in Nicotiana benthamiana Leaves: New Insights in Substrate Specificities with Relevance for Fabry Disease
por: Kytidou, Kassiani, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_mqk959opojkho5b053ca606k68